Day

January 21, 2018
Aradigm, the company that submitted Linhaliq to the FDA for approval, announced that they had received a complete response letter (CRL) from the FDA stating that they would not approve the treatment at this time. Many of you have communicated recently with the FDA about the unmet needs for bronchiectasis patients. You told them your...
Read More

WHAT IS NTM?

“NTM” is short for Nontuberculous Mycobacteria. NTM disease is a serious chronic lung illness.

Learn More